FDA clears Bio­gen, Sage's pill for post­par­tum de­pres­sion; What will Roivant, Bridge­Bio do next?; EQRx be­comes his­to­ry; Non-opi­oid pain drugs face piv­otal mo­ment; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

On Sep­tem­ber 20, we will be host­ing an awards gala in Boston for this year’s End­points 11, a group of the most promis­ing biotechs in the glob­al in­dus­try as se­lect­ed by an End­points team led by founder John Car­roll. Join us for an evening of din­ner, drinks and net­work­ing to meet the fu­ture of biotech. You can learn more de­tails and re­serve your seats here.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER